Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 2
Submit an article Journal homepage
13,497
Views
36
CrossRef citations to date
0
Altmetric
Articles

Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy

David LundgrenDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; View further author information
,
Vincy EklöfDepartment of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden; View further author information
,
Richard PalmqvistDepartment of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden; View further author information
,
Johan HultdinDepartment of Medical Biosciences Division of Clinical Chemistry, Umeå University, SwedenView further author information
&
Pontus KarlingDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5607-0118View further author information
ORCID Icon
Pages 152-157 | Received 04 Nov 2018, Accepted 16 Dec 2018, Published online: 24 Jan 2019

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Amanda Ricciuto & Anne M. Griffiths. (2019) Clinical value of fecal calprotectin. Critical Reviews in Clinical Laboratory Sciences 56:5, pages 307-320.
Read now

Articles from other publishers (35)

Natalie Rodriguez, Soma Kumar, Jun Mo & Phillipp Hartmann. (2024) Collagenous gastritis with elevated fecal calprotectin in a pediatric patient. JPGN Reports.
Crossref
Nisha E. Mathew, Delyse McCaffrey, Adam K. Walker, Kylie-Ann Mallitt, Anne Masi, Margaret J. Morris & Chee Y. Ooi. (2024) The search for gastrointestinal inflammation in autism: a systematic review and meta-analysis of non-invasive gastrointestinal markers. Molecular Autism 15:1.
Crossref
Oliver Bjurström & Pontus Karling. (2024) The association between drugs and repeated treatment with budesonide in patients with microscopic colitis: a retrospective observational study. Therapeutic Advances in Gastroenterology 17.
Crossref
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ayah Talal Zaidalkiani, Athanasios Alexiou, Marios Papadakis, Mostafa M. Bahaa, Ammar AL-Faraga & Gaber El-Saber Batiha. (2024) Calprotectin in Parkinsonian disease: Anticipation and dedication. Ageing Research Reviews 93, pages 102143.
Crossref
Isabelle Traini, Sin Y. Chan, Jessica Menzies, Jennifer Hughes, Michael J. Coffey, Isabelle R. McKay, Chee Y. Ooi, Steven T. Leach & Usha Krishnan. (2023) Intestinal dysbiosis and inflammation in children with repaired esophageal atresia. Journal of Pediatric Gastroenterology and Nutrition 78:1, pages 43-51.
Crossref
Zlatica Rendek, Magnus Falk, Ewa Grodzinsky, Stergios Kechagias & Henrik Hjortswang. (2023) Diagnostic value of fecal calprotectin in primary care patients with gastrointestinal symptoms: A retrospective Swedish cohort study. JGH Open 7:10, pages 708-716.
Crossref
Jennifer Murray, Klaartje B Kok & Ruth M Ayling. (2023) Fecal Calprotectin in Gastrointestinal Disease. Clinical Chemistry 69:7, pages 699-710.
Crossref
Helen Bruce, Jacqueline Osypiw, Geeta Prajapati-Jha, Shane O’Driscoll, Martin Brealey & Sally C Benton. (2023) Comparison of faecal calprotectin using two collection and extraction strategies for the BÜHLMANN CALEX® Cap – possible implications for clinical cut-offs?. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 60:4, pages 236-242.
Crossref
Zlatica Rendek, Magnus Falk, Ewa Grodzinsky, Stergios Kechagias & Henrik Hjortswang. (2022) Oral omeprazole and diclofenac intake is associated with increased faecal calprotectin levels: a randomised open-label clinical trial. European Journal of Gastroenterology & Hepatology 35:1, pages 52-58.
Crossref
A. A. Sheptulin, S. S. Kardasheva & A. A. Kurbatova. (2022) Diagnostic Possibilities of Determining the Level of Faecal Calprotectin in Clinical Practice. Russian Journal of Gastroenterology, Hepatology, Coloproctology 32:6, pages 53-59.
Crossref
Viggo Hamberg, Johan K. Wallman, Elisabeth Mogard, Elisabet Lindqvist, Tor Olofsson & Kristofer Andréasson. (2022) Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis. Rheumatology International 43:5, pages 961-967.
Crossref
Tiziana Mundula, Edda Russo, Lavinia Curini, Francesco Giudici, Andrea Piccioni, Francesco Franceschi & Amedeo Amedei. (2022) Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic. Current Medicinal Chemistry 29:33, pages 5370-5396.
Crossref
Hannah E. Wrigley-Carr, Josie M. van Dorst & Chee Y. Ooi. (2022) Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes. Medicine in Microecology 13, pages 100057.
Crossref
Maja Czerwińska-Rogowska, Karolina Skonieczna-Żydecka, Krzysztof Kaseja, Karolina Jakubczyk, Joanna Palma, Marta Bott-Olejnik, Sławomir Brzozowski & Ewa Stachowska. (2022) Kitchen Diet vs. Industrial Diets—Impact on Intestinal Barrier Parameters among Stroke Patients. International Journal of Environmental Research and Public Health 19:10, pages 6168.
Crossref
Debora Compare, Kok-Ann Gwee & Gerardo Nardone. 2022. Colonic Diverticular Disease. Colonic Diverticular Disease 129 141 .
Shin Young Park, Sang Pyung Lee & Woo Jin Kim. (2021) Fecal Calprotectin Is Increased in Stroke. Journal of Clinical Medicine 11:1, pages 159.
Crossref
Michel Kmeid, Soe Htet Arker, Adam Petchers, Georgi Lukose, Hua Li, Edward C Lee, Cary M Qualia, Mustafa Erdem Arslan & Hwajeong Lee. (2021) Appendiceal inflammation in colectomy is independently correlated with early pouchitis following ileal pouch anal anastomosis in ulcerative colitis and indeterminate colitis. Annals of Diagnostic Pathology 55, pages 151838.
Crossref
Almina Jukic, Latifa Bakiri, Erwin F. Wagner, Herbert Tilg & Timon E. Adolph. (2021) Calprotectin: from biomarker to biological function. Gut 70:10, pages 1978-1988.
Crossref
Eric Guillemard, Marion Poirel, Florent Schäfer, Laurent Quinquis, Caroline Rossoni, Christian Keicher, Frank Wagner, Hania Szajewska, Frédéric Barbut, Muriel Derrien & Peter Malfertheiner. (2021) A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after Helicobacter pylori Therapy. Nutrients 13:9, pages 3171.
Crossref
Nicholas J. Ashton, Shorena Janelidze, Ahmad Al Khleifat, Antoine Leuzy, Emma L. van der Ende, Thomas K. Karikari, Andrea L. Benedet, Tharick A. Pascoal, Alberto Lleó, Lucilla Parnetti, Daniela Galimberti, Laura Bonanni, Andrea Pilotto, Alessandro Padovani, Jan Lycke, Lenka Novakova, Markus Axelsson, Latha Velayudhan, Gil D. Rabinovici, Bruce Miller, Carmine Pariante, Naghmeh Nikkheslat, Susan M. Resnick, Madhav Thambisetty, Michael Schöll, Gorka Fernández-Eulate, Francisco J. Gil-Bea, Adolfo López de Munain, Ammar Al-Chalabi, Pedro Rosa-Neto, Andre Strydom, Per Svenningsson, Erik Stomrud, Alexander Santillo, Dag Aarsland, John C. van Swieten, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Abdul Hye & Oskar Hansson. (2021) A multicentre validation study of the diagnostic value of plasma neurofilament light. Nature Communications 12:1.
Crossref
Yee Man Kan, Sin Yan Chu & Ching Kong Loo. (2021) Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases. JGH Open 5:6, pages 647-652.
Crossref
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński & Małgorzata Krzystek-Korpacka. (2021) Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 10:10, pages 2203.
Crossref
Bahareh Ebrahimi, MohamadAli Nazarinia & Mina Molayem. (2020) Calprotectin, an available prognostic biomarker in systemic sclerosis: a systematic review. Clinical Rheumatology 40:5, pages 1709-1715.
Crossref
Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese & Laurent Peyrin‐Biroulet. (2021) International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterology Journal 9:4, pages 451-460.
Crossref
Lovro Lamot, Marijana Miler, Rudolf Vukojević, Mandica Vidović, Mirta Lamot, Ivana Trutin, Nora Nikolac Gabaj & Miroslav Harjaček. (2021) The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients. Frontiers in Medicine 8.
Crossref
Floris Westerink, Inge Huibregtse, Marieke De Hoog, Sjoerd Bruin, Eelco Meesters, Desiderius Brandjes & Victor Gerdes. (2021) Faecal Inflammatory Biomarkers and Gastrointestinal Symptoms after Bariatric Surgery: A Longitudinal Study. Inflammatory Intestinal Diseases 6:2, pages 109-116.
Crossref
Henrik Hovstadius, David Lundgren & Pontus Karling. (2021) Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study. Inflammatory Intestinal Diseases 6:2, pages 101-108.
Crossref
Eliza Lężyk-Ciemniak, Magdalena Tworkiewicz, Dominika Wilczyńska, Anna Szaflarska-Popławska & Aneta Krogulska. (2021) Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice. Medical Principles and Practice 30:4, pages 311-319.
Crossref
Vanessa Stadlbauer, Lara Engertsberger, Irina Komarova, Nicole Feldbacher, Bettina Leber, Gerald Pichler, Nicole Fink, Monika Scarpatetti, Walter Schippinger, Reinhold Schmidt & Angela Horvath. (2020) Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study. BMC Geriatrics 20:1.
Crossref
Carmelo Scarpignato, Michio Hongo, Justin C. Y. Wu, Christian Lottrup, Adriana Lazarescu, Ellen Stein & Richard H. Hunt. (2020) Pharmacologic treatment of GERD: Where we are now, and where are we going?. Annals of the New York Academy of Sciences 1482:1, pages 193-212.
Crossref
Tianyi Ma, Meng Wu, Shengnan Jia & Lanlan Yang. (2020) Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies. International Journal of Colorectal Disease 35:12, pages 2157-2169.
Crossref
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke & Katarzyna Neubauer. (2020) Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 10:6, pages 367.
Crossref
Lung-Yi MakTeresa S. M. TongKa-Shing CheungLi-Jia ChenKa-Luen LuiKam-Shing LauWai K. Leung. (2020) Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 11:3, pages e00138.
Crossref
Juan Egea Valenzuela, Elena Iglesias Jorquera, Francisco Javier Álvarez-Higueras, María Muñoz Tornero, Ana Pereñíguez López, Esther Estrella Díez & Fernando Alberca de las Parras. (2020) Factors associated with the presence of abnormal levels of fecal calprotectin in patients with negative panenteric studies. Revista Española de Enfermedades Digestivas 112.
Crossref
Ben Kang. (2019) Can proton pump inhibitors cause intestinal inflammation in children?. Korean Journal of Pediatrics 62:10, pages 384-385.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.